Melissa A. Linden, Susan J. Burke, Humza A. Pirzadah, Tai-Yu Huang, Heidi M. Batdorf, Walid K. Mohammed, . . . Robert C. Noland. (2023). Pharmacological inhibition of lipolysis prevents adverse metabolic outcomes during glucocorticoid administration. Elsevier.
Chicago Style (17th ed.) CitationMelissa A. Linden, et al. Pharmacological Inhibition of Lipolysis Prevents Adverse Metabolic Outcomes During Glucocorticoid Administration. Elsevier, 2023.
MLA (9th ed.) CitationMelissa A. Linden, et al. Pharmacological Inhibition of Lipolysis Prevents Adverse Metabolic Outcomes During Glucocorticoid Administration. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.